__NUXT_JSONP__("/drugs/SerineThreonine_Kinase_Inhibitor_CBP501", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"565434-85-7",chebiId:b,chemicalFormula:b,definition:"A peptide with G2 checkpoint-abrogating activity. G2 checkpoint inhibitor CBP501 inhibits multiple serine\u002Fthreonine kinases, including MAPKAP-K2, C-Tak1, and CHK1, that phosphorylate serine 216 of the dual-specific phosphatase Cdc25C (cell division checkpoint 25 C); disruption of Cdc25C activity results in the inhibition of Cdc25C dephosphorylation of the mitotic cyclin-dependent kinase complex Cdc2\u002Fcyclin B, preventing entry into the mitotic phase of the cell cycle.",fdaUniiCode:"XH2662798I",identifier:"C71529",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C61074"],synonyms:["CBP 501","CBP-501","CBP501","Cdc25C Phosphatase (211-221)","D-Arginine, 4-Benzoyl-D-phenylalanyl-D-seryl-D-tryptophyl-D-seryl-2,3,4,5,6-pentafluoro-D-phenylalanyl-3-cyclohexyl-D-alanyl-D-arginyl-D- arginyl-D-arginyl-D-glutaminyl-D-arginyl-",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FSerineThreonine_Kinase_Inhibitor_CBP501",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("SerineThreonine_Kinase_Inhibitor_CBP501","","Serine\u002FThreonine Kinase Inhibitor CBP501","2021-10-30T13:43:39.033Z")));